New Delhi [India], September 9 (ANI/BusinessWire India): Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), a global leader in medical technology, today announced the launch of FineGlide, Sterile Pen Needle for patients requiring regular insulin injections or other self-medication. Designed to be compatible with most commonly available pen devices in India, Fineglide raises the bar for patient comfort and thereby, drug compliance. Making the announcement, Managing Director of Terumo India, Shishir Agarwal said, "Patient comfort and convenience are critical attributes that have significant impact on their adherence to therapy. We are delighted to introduce FineGlide to patients and healthcare providers in India as it raises the bar for patient comfort." It is estimated that close to 78 million patients in India are having Diabetes, of these about 12 per cent patients require insulin daily to manage the disease and also there are other therapies wherein self-inject
/PRNewswire/ The Global Home Health Hub Market (2022-2027) by Products & Services, Patient Monitoring, End User, Geography, Competitive Analysis and the.